Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 12:02 AM
Ignite Modification Date:
2025-12-25 @ 12:02 AM
NCT ID:
NCT01632358
Brief Summary:
The study will assess the safety, tolerability and pharmacokinetics of TAP311 in patients with dyslipidemia.
Study:
NCT01632358
Study Brief:
Protocol Section:
NCT01632358